Security Snapshot

GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS) Institutional Ownership

CUSIP: G3855L106

13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

54

Shares (Excl. Options)

47,551,006

Price

$14.06

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+987,155
Value change
+$17,053,566
Number of holders
54
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
61,857,977
SEC-reported price per share
$22.38
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • GHRS - GH Research PLC - Ordinary Shares, nominal value $0.025 per share is tracked under CUSIP G3855L106.
  • 54 institutions reported positions in Q1 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 53 to 54 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $591,366,552 to $668,548,105.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 54 institutions filings for Q1 2026.

Open SEC evidence

Security key

G3855L106

Latest holder period

Q1 2026

13F holders

54

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
GHRS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lynx1 Capital Management LP 17% +3.5% $202,457,447 +$6,709,772 10,763,288 +3.4% Lynx1 Capital Management LP 31 Mar 2026
BIOTECHNOLOGY VALUE FUND L P 14% $84,128,095 8,827,712 BVF PARTNERS L P/IL 31 Mar 2025
RA CAPITAL MANAGEMENT, L.P. 12% +11% $123,210,987 +$11,749,386 7,676,697 +11% RA Capital Management, L.P. 30 Jun 2025
RTW INVESTMENTS, LP 8.9% $52,412,799 5,499,769 RTW Investments, LP 31 Mar 2025
FMR LLC 8.2% +19% $81,728,927 +$13,523,168 5,092,145 +20% FMR LLC 30 Jun 2025
Terwey Theis H 2.9% -59% $25,515,004 -$41,593,509 1,784,266 -62% Terwey Theis H 30 Sep 2025

As of 31 Mar 2026, 54 institutional investors reported holding 47,551,006 shares of GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS). This represents 77% of the company’s total 61,857,977 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
76%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Lynx1 Capital Management LP 17% 10,763,288 +3.4% 24% $151,331,829
BVF INC/IL 14% 8,650,158 -2% 3.9% $121,621,221
RA CAPITAL MANAGEMENT, L.P. 12% 7,676,697 0% 1.1% $107,934,360
RTW INVESTMENTS, LP 9.6% 5,933,815 0% 0.83% $83,429,439
FMR LLC 8.3% 5,136,045 0% 0% $72,212,792
Avoro Capital Advisors LLC 2.9% 1,800,000 0% 0.25% $25,308,000
TORONTO DOMINION BANK 2.3% 1,397,873 0.04% $19,654,094
Troluce Capital Advisors LLC 1.6% 990,472 +165% 1.5% $13,926,036
MILLENNIUM MANAGEMENT LLC 1.5% 937,898 +217% 0.01% $13,186,846
Jefferies Financial Group Inc. 1.2% 712,300 0% 0.12% $10,014,938
5AM Venture Management, LLC 0.93% 572,665 0% 2.2% $8,051,670
BlackRock, Inc. 0.74% 455,618 +4.9% 0% $6,405,989
UBS Group AG 0.67% 412,416 +13% 0% $5,798,569
Squadron Capital Management LLC 0.53% 325,000 +3.2% 1.8% $4,569,500
Foresite Capital Management VI LLC 0.51% 315,492 0.96% $4,435,818
BOOTHBAY FUND MANAGEMENT, LLC 0.46% 282,891 +152% 0.09% $3,977,447
CenterBook Partners LP 0.35% 216,574 -24% 0.16% $3,045,030
HighVista Strategies LLC 0.34% 213,212 -11% 0.83% $2,997,761
MARSHALL WACE, LLP 0.15% 91,108 -62% 0% $1,280,978
Occam Crest Management LP 0.13% 80,000 0.71% $1,124,800
Trexquant Investment LP 0.11% 69,808 +27% 0.01% $981,500
AdvisorShares Investments LLC 0.11% 67,034 -0.12% 0.17% $942,498
CITADEL ADVISORS LLC 0.11% 65,464 +149% 0% $920,424
XTX Topco Ltd 0.08% 52,090 +17% 0.01% $732,385
GOLDMAN SACHS GROUP INC 0.07% 44,795 -45% 0% $629,818

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 47,551,006 $668,548,105 +$17,053,566 $14.06 54
2025 Q4 46,564,278 $591,366,552 +$19,014,477 $12.70 53
2025 Q3 44,533,428 $618,134,274 +$14,411,795 $14.30 47
2025 Q2 43,554,151 $530,925,463 +$12,435,267 $12.19 37
2025 Q1 42,619,365 $470,078,472 +$132,646,472 $11.03 35
2024 Q4 30,702,522 $214,921,353 +$703,147 $7.00 31
2024 Q3 30,520,551 $204,184,484 +$470,359 $6.69 28
2024 Q2 30,425,860 $354,768,061 +$9,911,656 $11.66 28
2024 Q1 29,598,383 $315,521,410 +$9,696,487 $10.66 32
2023 Q4 29,604,263 $171,708,593 +$1,756,706 $5.80 35
2023 Q3 29,004,299 $291,487,763 -$8,205,765 $10.05 29
2023 Q2 29,634,294 $351,618,806 -$693,689 $11.86 34
2023 Q1 29,693,376 $237,250,217 -$9,782,816 $7.99 29
2022 Q4 30,892,511 $299,454,602 -$7,759,406 $9.72 32
2022 Q3 31,599,032 $367,179,200 -$9,454,337 $11.62 33
2022 Q2 32,559,951 $324,989,656 +$3,737,200 $9.98 33
2022 Q1 32,084,312 $586,822,000 +$37,199,278 $18.29 30
2021 Q4 30,046,921 $700,993,000 +$26,953,821 $23.33 29
2021 Q3 28,509,902 $625,158,000 +$21,272,275 $22.06 29
2021 Q2 27,592,126 $593,693,000 +$593,693,000 $21.73 34
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .